TARRIFF SCOTT (CEO) reported 1 transaction at EAGLE PHARMACEUTICALS, INC.
Review the transaction codes below to understand the nature of each event.
Filed: 1/9/2023ACC: 0001209191-23-002566
DirectorOfficer· CEO
Since Jun 2018
-3.83K
Net shares
Net seller
$112.0K
Total sold
0
Open market trades
0B · 0S
1
Total transactions
3.83K disposed
Non-Derivative Transactions1
Common Stock
Direct
Shares
−3.83K
Price / share
$29.26
Trade value
$111.98K
% of position
0.2%
1/5/2023
1.58M→1.58M
Total
Net shares
−3.83K
Net value
-$111.98K
| Security | Date | Type | Shares | Price / Share | Trade Value | % of Position | Held Before | Held After |
|---|---|---|---|---|---|---|---|---|
| Common Stock Direct | 1/5/2023 | F · Tax Withholding | −3.83K | $29.26 | $111.98K | 0.2% | 1.58M | 1.58M |
| Total | −3.83K | -$111.98K | ||||||
Derivative Transactions0
No derivative transactions reported